Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil
Main Author: | |
---|---|
Publication Date: | 2023 |
Other Authors: | , , , , , , , , , |
Format: | Article |
Language: | eng |
Source: | São Paulo medical journal (Online) |
Download full: | https://periodicosapm.emnuvens.com.br/spmj/article/view/469 |
Summary: | BACKGROUND: Hesitation and refusal to take a second dose of the vaccine for coronavirus disease 19 (COVID-19) are prevalent. OBJECTIVES: We aimed to identify predictive factors for hesitation or refusal and describe groups with higher rates of vaccine hesitancy. DESIGN AND SETTING: A cross-sectional study in Assis City, Brazil. METHODS: The study included adults who passed the due date for taking the COVID-19 second dose vaccine. Participants were recruited in December 2021 using a mobile-based text message. Sociodemographic and clinical data and reasons for hesitance were collected. The outcome was the attitude towards completing the recommended second dose of the vaccine. Bivariate and multivariate Poisson analyses were performed to determine the adjusted predictors. RESULTS: Participants between 30–44 years of age had a 2.41 times higher prevalence of hesitation than those aged 18–29 years. In addition, people who had adverse events or previously had COVID-19 had 4.7 and 5.4 times higher prevalences of hesitation, respectively (P value < 0.05). CONCLUSION: We found a significant group of adults aged between 30–44 years who refused the second dose of the COVID-19 vaccine. Furthermore, those who reported adverse effects after the first dose and those who had COVID-19 previously were a significant group for refusal. |
id |
APM-1_12a9fb37d1b170081e629b7c7a9b4526 |
---|---|
oai_identifier_str |
oai:ojs.diagnosticoetratamento.emnuvens.com.br:article/469 |
network_acronym_str |
APM-1 |
network_name_str |
São Paulo medical journal (Online) |
repository_id_str |
|
spelling |
Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of BrazilCOVID-19Vaccination hesitancyVaccinationVaccination refusalAnti-vaccination movementBACKGROUND: Hesitation and refusal to take a second dose of the vaccine for coronavirus disease 19 (COVID-19) are prevalent. OBJECTIVES: We aimed to identify predictive factors for hesitation or refusal and describe groups with higher rates of vaccine hesitancy. DESIGN AND SETTING: A cross-sectional study in Assis City, Brazil. METHODS: The study included adults who passed the due date for taking the COVID-19 second dose vaccine. Participants were recruited in December 2021 using a mobile-based text message. Sociodemographic and clinical data and reasons for hesitance were collected. The outcome was the attitude towards completing the recommended second dose of the vaccine. Bivariate and multivariate Poisson analyses were performed to determine the adjusted predictors. RESULTS: Participants between 30–44 years of age had a 2.41 times higher prevalence of hesitation than those aged 18–29 years. In addition, people who had adverse events or previously had COVID-19 had 4.7 and 5.4 times higher prevalences of hesitation, respectively (P value < 0.05). CONCLUSION: We found a significant group of adults aged between 30–44 years who refused the second dose of the COVID-19 vaccine. Furthermore, those who reported adverse effects after the first dose and those who had COVID-19 previously were a significant group for refusal.São Paulo Medical JournalSão Paulo Medical Journal2023-05-04info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://periodicosapm.emnuvens.com.br/spmj/article/view/469São Paulo Medical Journal; Vol. 141 No. 3 (2023); 1-7São Paulo Medical Journal; v. 141 n. 3 (2023); 1-71806-9460reponame:São Paulo medical journal (Online)instname:Associação Paulista de Medicinainstacron:APMenghttps://periodicosapm.emnuvens.com.br/spmj/article/view/469/423https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessFilho, Carlos Izaias SartorãoZoqui, Mariana CostaDuarte, Douglas OtomoRibeiro, Edy AlysonBisetto, Vinicius César QueirozCachoni, Lara Escobar GaviãoSartorão, Ana Luísa VarroneTerribile, Diogo CoutinhoMello, Beatriz Balsimelli deNeto, Carlos Izaias SartorãoMello, Roberto de2023-07-07T12:22:24Zoai:ojs.diagnosticoetratamento.emnuvens.com.br:article/469Revistahttp://www.scielo.br/spmjPUBhttps://old.scielo.br/oai/scielo-oai.phprevistas@apm.org.br1806-94601516-3180opendoar:2023-07-07T12:22:24São Paulo medical journal (Online) - Associação Paulista de Medicinafalse |
dc.title.none.fl_str_mv |
Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil |
title |
Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil |
spellingShingle |
Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil Filho, Carlos Izaias Sartorão COVID-19 Vaccination hesitancy Vaccination Vaccination refusal Anti-vaccination movement |
title_short |
Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil |
title_full |
Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil |
title_fullStr |
Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil |
title_full_unstemmed |
Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil |
title_sort |
Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil |
author |
Filho, Carlos Izaias Sartorão |
author_facet |
Filho, Carlos Izaias Sartorão Zoqui, Mariana Costa Duarte, Douglas Otomo Ribeiro, Edy Alyson Bisetto, Vinicius César Queiroz Cachoni, Lara Escobar Gavião Sartorão, Ana Luísa Varrone Terribile, Diogo Coutinho Mello, Beatriz Balsimelli de Neto, Carlos Izaias Sartorão Mello, Roberto de |
author_role |
author |
author2 |
Zoqui, Mariana Costa Duarte, Douglas Otomo Ribeiro, Edy Alyson Bisetto, Vinicius César Queiroz Cachoni, Lara Escobar Gavião Sartorão, Ana Luísa Varrone Terribile, Diogo Coutinho Mello, Beatriz Balsimelli de Neto, Carlos Izaias Sartorão Mello, Roberto de |
author2_role |
author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Filho, Carlos Izaias Sartorão Zoqui, Mariana Costa Duarte, Douglas Otomo Ribeiro, Edy Alyson Bisetto, Vinicius César Queiroz Cachoni, Lara Escobar Gavião Sartorão, Ana Luísa Varrone Terribile, Diogo Coutinho Mello, Beatriz Balsimelli de Neto, Carlos Izaias Sartorão Mello, Roberto de |
dc.subject.por.fl_str_mv |
COVID-19 Vaccination hesitancy Vaccination Vaccination refusal Anti-vaccination movement |
topic |
COVID-19 Vaccination hesitancy Vaccination Vaccination refusal Anti-vaccination movement |
description |
BACKGROUND: Hesitation and refusal to take a second dose of the vaccine for coronavirus disease 19 (COVID-19) are prevalent. OBJECTIVES: We aimed to identify predictive factors for hesitation or refusal and describe groups with higher rates of vaccine hesitancy. DESIGN AND SETTING: A cross-sectional study in Assis City, Brazil. METHODS: The study included adults who passed the due date for taking the COVID-19 second dose vaccine. Participants were recruited in December 2021 using a mobile-based text message. Sociodemographic and clinical data and reasons for hesitance were collected. The outcome was the attitude towards completing the recommended second dose of the vaccine. Bivariate and multivariate Poisson analyses were performed to determine the adjusted predictors. RESULTS: Participants between 30–44 years of age had a 2.41 times higher prevalence of hesitation than those aged 18–29 years. In addition, people who had adverse events or previously had COVID-19 had 4.7 and 5.4 times higher prevalences of hesitation, respectively (P value < 0.05). CONCLUSION: We found a significant group of adults aged between 30–44 years who refused the second dose of the COVID-19 vaccine. Furthermore, those who reported adverse effects after the first dose and those who had COVID-19 previously were a significant group for refusal. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-05-04 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://periodicosapm.emnuvens.com.br/spmj/article/view/469 |
url |
https://periodicosapm.emnuvens.com.br/spmj/article/view/469 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://periodicosapm.emnuvens.com.br/spmj/article/view/469/423 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
São Paulo Medical Journal São Paulo Medical Journal |
publisher.none.fl_str_mv |
São Paulo Medical Journal São Paulo Medical Journal |
dc.source.none.fl_str_mv |
São Paulo Medical Journal; Vol. 141 No. 3 (2023); 1-7 São Paulo Medical Journal; v. 141 n. 3 (2023); 1-7 1806-9460 reponame:São Paulo medical journal (Online) instname:Associação Paulista de Medicina instacron:APM |
instname_str |
Associação Paulista de Medicina |
instacron_str |
APM |
institution |
APM |
reponame_str |
São Paulo medical journal (Online) |
collection |
São Paulo medical journal (Online) |
repository.name.fl_str_mv |
São Paulo medical journal (Online) - Associação Paulista de Medicina |
repository.mail.fl_str_mv |
revistas@apm.org.br |
_version_ |
1825135056706863104 |